5.27
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt RCEL?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$5.23
Offen:
$5.15
24-Stunden-Volumen:
89,627
Relative Volume:
0.14
Marktkapitalisierung:
$140.28M
Einnahmen:
$50.14M
Nettoeinkommen (Verlust:
$-35.38M
KGV:
-3.7643
EPS:
-1.4
Netto-Cashflow:
$-39.46M
1W Leistung:
-3.66%
1M Leistung:
+15.57%
6M Leistung:
-41.12%
1J Leistung:
-49.38%
Avita Medical Inc Stock (RCEL) Company Profile
Firmenname
Avita Medical Inc
Sektor
Branche
Telefon
661-568-1317
Adresse
28159 AVENUE STANFORD, VALENCIA, CA
Vergleichen Sie RCEL mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
RCEL
Avita Medical Inc
|
5.27 | 141.31M | 50.14M | -35.38M | -39.46M | -1.40 |
![]()
ABT
Abbott Laboratories
|
133.27 | 228.66B | 43.11B | 13.94B | 6.78B | 7.9963 |
![]()
BSX
Boston Scientific Corp
|
96.24 | 140.69B | 18.49B | 2.50B | 3.49B | 1.6801 |
![]()
SYK
Stryker Corp
|
370.00 | 139.51B | 23.82B | 2.92B | 4.02B | 7.5574 |
![]()
MDT
Medtronic Plc
|
96.54 | 122.60B | 34.20B | 4.69B | 5.30B | 3.6218 |
![]()
EW
Edwards Lifesciences Corp
|
73.36 | 42.83B | 5.69B | 1.41B | 577.90M | 6.9828 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-08-08 | Herabstufung | BTIG Research | Neutral → Sell |
2024-12-24 | Eingeleitet | D. Boral Capital | Buy |
2024-04-11 | Herabstufung | BTIG Research | Buy → Neutral |
2023-06-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
2021-03-02 | Eingeleitet | Piper Sandler | Overweight |
2020-08-27 | Eingeleitet | BofA Securities | Buy |
2020-04-21 | Eingeleitet | Oppenheimer | Outperform |
2020-03-03 | Eingeleitet | BTIG Research | Buy |
Alle ansehen
Avita Medical Inc Aktie (RCEL) Neueste Nachrichten
Is AVITA Medical Inc. stock a buy for dividend growthJuly 2025 PostEarnings & Daily Price Action Insights - newser.com
Is AVITA Medical Inc. reversing from oversold territoryExit Point & Stepwise Trade Signal Guides - newser.com
Will AVITA Medical Inc. stock recover faster than peersStop Loss & Accurate Entry/Exit Alerts - newser.com
How AVITA Medical Inc. stock performs during Fed tightening cyclesWeekly Trend Recap & High Return Trade Opportunity Guides - newser.com
Real time social sentiment graph for AVITA Medical Inc.July 2025 Review & Fast Gain Stock Tips - newser.com
Is it too late to sell AVITA Medical Inc.July 2025 Macro Moves & Capital Efficiency Focused Ideas - newser.com
Is AVITA Medical Inc. stock a top pick in earnings seasonJuly 2025 Trends & Long-Term Capital Growth Strategies - newser.com
What technical models suggest about AVITA Medical Inc.’s comeback - newser.com
How risky is AVITA Medical Inc. stock now2025 Retail Activity & Precise Swing Trade Entry Alerts - newser.com
Applying sector rotation models to AVITA Medical Inc.2025 Buyback Activity & Expert Verified Stock Movement Alerts - newser.com
AVITA Medical Inc. stock trend forecastSell Signal & High Win Rate Trade Tips - newser.com
Why AVITA Medical Inc. stock remains resilient2025 Dividend Review & Technical Entry and Exit Alerts - newser.com
Using economic indicators to assess AVITA Medical Inc. potentialBond Market & Short-Term Trading Opportunity Alerts - newser.com
Smart tools for monitoring AVITA Medical Inc.’s price actionJuly 2025 Update & Technical Pattern Alert System - newser.com
Weiss Ratings Reaffirms Sell (D-) Rating for Avita Medical (NASDAQ:RCEL) - MarketBeat
AVITA REMINDER: Bragar Eagel & Squire, P.C. Reminds AVITA - GlobeNewswire
MAREX REMINDER: Bragar Eagel & Squire, P.C. Reminds Marex Group Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Marex Stockholders - GlobeNewswire Inc.
How to interpret RSI for AVITA Medical Inc. stockJuly 2025 Decliners & Advanced Technical Signal Analysis - newser.com
Custom strategy builders for tracking AVITA Medical Inc.Trade Entry Report & Free Low Drawdown Momentum Trade Ideas - newser.com
What drives AVITA Medical Inc stock priceStraddle and Strangle Trades & Bull Bear Market Updates - earlytimes.in
Understanding AVITA Medical Inc.’s price movementJuly 2025 Weekly Recap & Advanced Swing Trade Entry Plans - newser.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc.RCEL - Eastern Progress
RCEL: Kirby McInerney LLP Continues Securities Investigation on Behalf of AVITA Medical, Inc. Investors - ACCESS Newswire
AVITA (RCEL) INVESTIGATION ALERT: Bragar Eagel & Squire, - GlobeNewswire
Upcoming Events - FinancialContent
AVITA Medical, Inc. (NASDAQ:RCEL) Surges 28% Yet Its Low P/S Is No Reason For Excitement - simplywall.st
Combining machine learning predictions for AVITA Medical Inc.Profit Target & Free Growth Oriented Trading Recommendations - newser.com
Applying Wyckoff theory to AVITA Medical Inc. stock2025 Momentum Check & Expert Curated Trade Ideas - newser.com
Avita Medical's RECELL System Secures CMS Reimbursement for Acute Wound Care - MarketScreener
CMS New Technology Add-On Payment Expands Access to RECELL® for Patients with Non-Burn Acute Wounds - Investing News Network
AVITA Medical (RCEL) Secures NTAP Reimbursement for RECELL - GuruFocus
$4,875 Per Treatment: AVITA Medical's RECELL System Gets Major Medicare Reimbursement Boost for Wound Care - Stock Titan
Securities Fraud Investigation Into AVITA Medical, Inc. - GlobeNewswire
Securities Fraud Investigation Into AVITA Medical, Inc. (RCEL) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - GlobeNewswire
Finanzdaten der Avita Medical Inc-Aktie (RCEL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Avita Medical Inc-Aktie (RCEL) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
O'Toole David D | CFO |
Aug 26 '25 |
Buy |
4.52 |
2,000 |
9,040 |
31,657 |
McNamara Robert | Director |
Aug 19 '25 |
Buy |
5.00 |
10,000 |
50,000 |
76,771 |
O'Toole David D | CFO |
Aug 12 '25 |
Buy |
4.81 |
2,000 |
9,620 |
29,657 |
McNamara Robert | Director |
Mar 06 '25 |
Buy |
8.30 |
11,000 |
91,300 |
56,749 |
McNamara Robert | Director |
Feb 20 '25 |
Buy |
10.09 |
10,000 |
100,900 |
45,749 |
O'Toole David D | CFO |
Feb 20 '25 |
Buy |
9.90 |
1,000 |
9,900 |
25,734 |
O'Toole David D | CFO |
Feb 19 '25 |
Buy |
10.25 |
1,000 |
10,250 |
24,734 |
Crowe Suzanne | Director |
Dec 09 '24 |
Buy |
13.15 |
486 |
6,391 |
36,912 |
O'Toole David D | CFO |
Dec 05 '24 |
Buy |
12.46 |
975 |
12,152 |
23,734 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):